Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
JERSEY, Channel Islands , Sept. 26, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Franz Walt , will present at the 2018 Cantor Fitzgerald Global Healthcare Conference on Wednesday,
View HTML
Toggle Summary Quotient Limited reports the submission of the initial IH CE mark filing and the successful completion of the key regulatory audits of its new BioCampus facility
Initial IH CE mark submission has been completed and filed on schedule Successful facility audits pave the way for an on time BioCampus ramp up JERSEY, Channel Islands , Sept. 25, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported: (i)
View HTML
Toggle Summary Quotient Limited Reports Senior Note Issuance and Warrant Cash Inflows and updates on MosaiQ Development and First Quarter Fiscal 2019 Financial Results
$48.8 million of proceeds from warrant exercises received through July 31 $36 million of additional senior notes issued and funded in June Initial SDS microarray verification and validation started Record reagent revenues recorded during the quarter JERSEY, Channel Islands , Aug.
View HTML
Toggle Summary Quotient Limited to Report Fiscal First Quarter 2019 Financial Results and Host Conference Call
JERSEY, Channel Islands , July 24, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2018 , will be released after market close on Monday, August 6, 2018 .
View HTML
Toggle Summary Quotient Limited Announces Details of Investor Day
JERSEY, Channel Islands , July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ headquarters in New York earlier today. Following the recent announcement of positive field trial data
View HTML
Toggle Summary Quotient Limited Announces Completion of Senior Secured Notes Offering
JERSEY, Channel Islands , July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million aggregate principal amount of its 12% Senior Secured Notes due 2023 (the “Notes”).
View HTML
Toggle Summary Quotient Limited to Host Investor Day on July 16, 2018
JERSEY, Channel Islands , June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July 16, 2018 from 9:00am – 1:00pm ET , in New York, NY . At the event, Franz Walt , Chief Executive
View HTML
Toggle Summary Quotient Limited Reports Concordance Data from the MosaiQ European Field Trial
Field trial concordance data exceed targeted criteria Planned issuance of $36 million in Senior Secured Notes JERSEY, Channel Islands , June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported concordance data for the initial MosaiQ
View HTML
Toggle Summary Quotient Limited Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Updates on CEO Appointment and MosaiQ™ European Field Trials
MosaiQ European field trial which commenced on May 17, 2018 is ongoing Franz Walt is appointed as Chief Executive Officer Fourth quarter product revenues of $6.1 million , up 29.6% JERSEY, Channel Islands , May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage
View HTML
Toggle Summary Quotient Limited appoints Franz Walt as Chief Executive Officer
JERSEY, Channel Islands , May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt , as its Chief Executive Officer. Mr Walt who retired earlier this year as the President of Siemens Healthineers ,
View HTML